| 1035 |
increased |
|
alpha-beta T cell receptor complex
(GO:0042105)
|
None
|
| 1034 |
increased |
antigen presentation trait
(VT:0001835)
|
Human leukocyte antigen complex
(FMA:84795)
|
None
|
| 1033 |
increased |
androgen biosynthetic process
(GO:0006702)
|
17beta-hydroxy-5alpha-androstan-3-one
(CHEBI:16330)
|
2273: Dihydrotestosterone (DHT) levels, increased
|
| 1032 |
increased |
|
aromatase
(PR:000006100)
|
None
|
| 1031 |
increased |
Immunosuppression
(IDO:0000610)
|
|
984: Impairment, T-cell dependent antibody response
|
| 1030 |
increased |
regulation of androgen receptor signaling pathway
(GO:0060765)
|
androgen receptor
(PR:000004191)
|
2274: Androgen receptor activation, increased
|
| 1029 |
increased |
hormone biosynthetic process
(GO:0042446)
|
17beta-hydroxy-5alpha-androstan-3-one
(CHEBI:16330)
|
None
|
| 1028 |
increased |
testosterone biosynthetic process
(GO:0061370)
|
testosterone
(CHEBI:17347)
|
2272: Testosterone levels, increased
|
| 1027 |
increased |
increased circulating LDL cholesterol level
(MP:0000182)
|
blood plasma
(UBERON:0001969)
|
None
|
| 1026 |
increased |
cholesterol biosynthetic process
(GO:0006695)
|
|
2270: Increased, cholesterol synthesis enzymes
|
| 1025 |
increased |
increased circulating total protein level
(MP:0005568)
|
|
None
|
| 1024 |
decreased |
decreased circulating total protein level
(MP:0005567)
|
|
None
|
| 1023 |
increased |
CNS demyelination
(HP:0007305)
|
|
2266: Demyelination, increased
|
| 1022 |
increased |
cell death
(GO:0008219)
|
oligodendrocyte
(CL:0000128)
|
2265: Oligodendrocyte death, increased
|
| 1021 |
increased |
|
lysophosphatidylcholine
(CHEBI:60479)
|
2263: Lysolecithin, increased
|
| 1020 |
decreased |
|
neuropathy target esterase
(PR:000012946)
|
2262: Neuropathy target esterase, inhibited
|
| 1019 |
increased |
Stress, Physiological
(MESH:D013312)
|
heart
(UBERON:0000948)
|
2239: Increased, Cardiac stress
|
| 1018 |
decreased |
blood circulation
(GO:0008015)
|
blood plasma
(UBERON:0001969)
|
2261: Decreased, blood plasma volume
|
| 1017 |
decreased |
decreased circulating sodium level
(MP:0005634)
|
blood plasma
(UBERON:0001969)
|
2237: Decreased, Plasma sodium concentrations
|
| 1016 |
decreased |
sodium ion import
(GO:0097369)
|
gill
(UBERON:0002535)
|
2236: Decreased, Sodium uptake in gills
|
| 1015 |
decreased |
regulation of body fluid levels
(GO:0050878)
|
blood plasma
(UBERON:0001969)
|
None
|
| 1014 |
decreased |
thyroid hormone transport
(GO:0070327)
|
monocarboxylate transporter 8
(PR:000014950)
|
2258: Inhibition, monocarboxylate transporter 8 (MCT8)
|
| 1013 |
decreased |
sodium:potassium-exchanging ATPase activity
(GO:0005391)
|
sodium:potassium-exchanging ATPase complex
(GO:0005890)
|
1562: Decreased Na/K ATPase activity
|
| 1012 |
decreased |
sulfotransferase activity
(GO:0008146)
|
estrogen sulfotransferase
(PR:000032783)
|
2155: Inhibition of Sulfotransferase E1 (SULT1E1)
|
| 1011 |
increased |
|
chromosome
(GO:0005694)
|
None
|